Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
JAMA Network Open
|
November 19, 2024
Hospitalization Following Outpatient Diagnosis of Respiratory Syncytial Virus in Adults
Suzanne N Landi, Diana C Garofalo, Maya Reimbaeva, et al.
Journal of the Royal Society of Medicine
|
July 5, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults
Catherine Hyams, George Qian, George Nava, et al.
The Lancet Regional Health. Europe
|
August 15, 2022
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study
Catherine Hyams, Robert Challen, Elizabeth Begier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 21, 2025
Estimated Vaccine Effectiveness for Respiratory Syncytial Virus-Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season
Sara Y Tartof, Negar Aliabadi, Gabriella Goodwin, et al.
Plos One
|
April 15, 2021
Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011-2018
John Njuma Libwea, Mark A Fletcher, Paul Koki Ndombo, et al.
Lancet Regional Health. Americas
|
June 8, 2026
Bivalent RSVpreF effectiveness against RSV-associated hospital or emergency department care over two seasons: a retrospective test-negative case control study
Sara Y Tartof, Negar Aliabadi, Evan Zasowski, et al.
BMJ Open
|
July 7, 2022
Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)
Konstantinos Liatsikos, Angela Hyder-Wright, Sherin Pojar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2023
Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial
Hamid Hassanzadeh, James Baber, Elizabeth Begier, et al.
BJGP Open
|
September 9, 2024
Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)
Polly Duncan, Ruth Mears, Elizabeth Begier, et al.
Influenza and Other Respiratory Viruses
|
March 15, 2026
Incidence of RSV- and Influenza-Associated Hospitalizations With Community-Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022-2024: APSG-J2 Study
Haruka Maeda, Shingo Masuda, Bhim Gopal Dhoubhadel, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
JAMA Network Open
|
November 19, 2024
Hospitalization Following Outpatient Diagnosis of Respiratory Syncytial Virus in Adults
Suzanne N Landi, Diana C Garofalo, Maya Reimbaeva, et al.
Journal of the Royal Society of Medicine
|
July 5, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults
Catherine Hyams, George Qian, George Nava, et al.
The Lancet Regional Health. Europe
|
August 15, 2022
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study
Catherine Hyams, Robert Challen, Elizabeth Begier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 21, 2025
Estimated Vaccine Effectiveness for Respiratory Syncytial Virus-Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season
Sara Y Tartof, Negar Aliabadi, Gabriella Goodwin, et al.
Plos One
|
April 15, 2021
Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011-2018
John Njuma Libwea, Mark A Fletcher, Paul Koki Ndombo, et al.
Lancet Regional Health. Americas
|
June 8, 2026
Bivalent RSVpreF effectiveness against RSV-associated hospital or emergency department care over two seasons: a retrospective test-negative case control study
Sara Y Tartof, Negar Aliabadi, Evan Zasowski, et al.
BMJ Open
|
July 7, 2022
Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)
Konstantinos Liatsikos, Angela Hyder-Wright, Sherin Pojar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2023
Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial
Hamid Hassanzadeh, James Baber, Elizabeth Begier, et al.
BJGP Open
|
September 9, 2024
Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)
Polly Duncan, Ruth Mears, Elizabeth Begier, et al.
Influenza and Other Respiratory Viruses
|
March 15, 2026
Incidence of RSV- and Influenza-Associated Hospitalizations With Community-Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022-2024: APSG-J2 Study
Haruka Maeda, Shingo Masuda, Bhim Gopal Dhoubhadel, et al.
Page
of 14